Nucleic acid amplification procedures can be used to overcome the limi
tations of direct probe hybridization assays. A number of such systems
have been described. Each method makes use of in vivo mechanisms of n
ucleic acid replication and repair to effect the amplification of nucl
eic acids in vitro. The strength of nucleic acid amplification technol
ogy, the ability to make many copies of a sequence present initially a
t a low concentration, is also its greatest potential weakness. Carryo
ver contamination of amplification products represents a great risk fo
r false positivity in these assay systems. Various methods have been d
eveloped to reduce the contamination risk, allowing the adaptation of
amplified probe assays far routine use in the clinical laboratory.